Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

By sjmartinez • January 29, 2025

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA. Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093/cid/ciae648. Epub ahead of print. PMID: 39873495.

Tags: antiretroviral agents, Cabotegravir, Health policy, Infectious Diseases, lenacapavir, Pre-exposure prophylaxis, Publications

Response to the Letter to the Editor on Laboratory Monitoring After Lentiviral Vector Exposure

Fujimoto GR, Wooley DP, Byers KB, Yang OO, Behrman AJ, Winters TH, Hudson TW. Response to the Letter to the Editor on Laboratory Monitoring After[...]

Update on HIV Chemoprevention

Blair CS, Cambou MC, Landovitz RJ. Update on HIV Chemoprevention. Annu Rev Med. 2025 Jan;76(1):43-56. doi: 10.1146/annurev-med-042823-013707. PMID: 39869431.

The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study

Nyemba DC, Joseph-Davey DL, Delany-Moretlwe S, Myer L, Johnson LF. The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy[...]